TickerFactsScreenerDevelopers

Wave Life Sciences Ltd. (WVE) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2016: -$31.93M2017: -$83.67M2018: -$22.86M2019: -$188.23M2020: -$115.98M2021: -$88.99M2022: -$127.78M2023: -$19.43M2024: -$151.03M2025: -$187.49M-$187.49M
2016Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$187.49M-24.1%
2024-$151.03M-677.2%
2023-$19.43M+84.8%
2022-$127.78M-43.6%
2021-$88.99M+23.3%
2020-$115.98M+38.4%
2019-$188.23M-723.3%
2018-$22.86M+72.7%
2017-$83.67M-162.1%
2016-$31.93M—